Transfer

News

All

Transfer

Public Engagement

Awards & Grants

Diabetes

Stem Cells

Environmental Health

Computational Health

Bioengeineering

Molecular Targets & Therapeutics

Pioneer Campus

AdobeStock_1251048900 Ein Pfeil bewegt sich über ansteigende Säulen nach oben

Transfer, HI-MAG,

Helmholtz Munich Partners in four Clusters of Excellence

Helmholtz Munich is a partner in four Clusters of Excellence selected for funding under the Excellence Strategy of the German federal and state governments. The projects, each granted a seven-year term, were announced by the German Research…

Angioplasty Procedure: Stent Deployment in a Coronary Artery AdobeStock_1219692882

AI, Transfer, New Research Findings, Computational Health, AIH,

AI-Powered Analysis of Stent Healing

A research team from Helmholtz Munich, the Technical University of Munich (TUM) and the TUM University Hospital has developed DeepNeo, an AI-powered algorithm that automates the process of analyzing coronary stents after implantation. The tool…

Samples on dry ice

Transfer,

Helmholtz Launches Task Force to Strengthen Prevention Research

The Helmholtz Association is pooling its commitment to prevention research with the launch of the Helmholtz Health Prevention Task Force. In a strategy paper published in Nature Medicine, the expert committee outlines initial concepts for more…

Eppstein Barr Virus

Transfer, New Research Findings, Molecular Targets and Therapeutics,

Start-up EBViously founded

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious…

Inceptor proteins moving from within a cell to its surface in a rat insulinoma cell, tagged with a fluorescent marker.

Transfer, New Research Findings, Diabetes, IDR,

Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies

In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor "Inceptor" and its role as a suppressor of the insulin signaling pathway. Now, the researchers have unlocked another, even more…

Life Science Factory Eröffnung Laborsicht

Transfer, Pioneer Campus,

Life Science Factory Expands: New Innovation Hub Opens in Munich in Cooperation with Helmholtz Munich

The Life Science Factory has opened its new site on the Helmholtz campus in Munich. Beginning in 2025, around 1,800 square meters of state-of-the-art laboratories and a flexible co-working space will be available for life science start-ups and…